Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy

Marc B Lande1, Donald L Batisky2, Juan C Kupferman3

  • 1Department of Pediatrics, University of Rochester, Rochester, NY.

The Journal of Pediatrics
|February 6, 2018
PubMed

Insights

Children with hypertension did not show improved neurocognitive function after one year of treatment compared to controls. Blood pressure control may influence cognitive outcomes in pediatric hypertension.

Area of Science:

  • Pediatric Neurology
  • Cardiology
  • Neuropsychology

Background:

  • Primary hypertension in children is a growing concern with potential long-term health implications.
  • Hypertension may affect cognitive development and function in pediatric populations.
  • Antihypertensive therapy is standard for managing elevated blood pressure.

Purpose of the Study:

  • To evaluate neurocognitive test performance changes in children with primary hypertension after initiating antihypertensive therapy.
  • To compare cognitive changes in hypertensive children receiving treatment against normotensive controls.

Main Methods:

  • A longitudinal study involving children with hypertension and normotensive controls.
  • Neurocognitive testing (general intelligence, attention, memory, executive function, processing speed) at baseline and 1-year follow-up.
  • Parental rating scales for executive function were also utilized.

Main Results:

  • Blood pressure significantly improved in the hypertension group after 1 year of treatment.
  • Both hypertensive and control groups showed similar improvements in specific cognitive tests (Rey Auditory Verbal Learning Test, Grooved Pegboard, Delis-Kaplan Executive Function System Tower Test).
  • Children with persistent hypertension showed limited cognitive gains, suggesting treatment effectiveness is crucial.

Conclusions:

  • Children with primary hypertension did not demonstrate neurocognitive improvements beyond age-related or practice effects after one year of antihypertensive therapy.
  • The extent of blood pressure reduction achieved through antihypertensive therapy may be a key factor influencing neurocognitive outcomes in pediatric hypertension.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
735
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.3K
Initiation of Translation02:33

Initiation of Translation

8.2K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
642
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.3K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.5K